Picture of Nephros logo

NEPH — Nephros News Story

0.000.00%
us flag iconLast trade - 00:00
IndustrialsAdventurousMicro CapNeutral

Nephros Inc expected to post a loss of 11  cents a share - Earnings Preview

* Nephros Inc  NEPH.OQ   NEPH.O  is expected to show a rise
in
quarterly revenue when it reports  results on February 23. 
    * The South Orange New Jersey-based  company is expected to
report
 a 22.0% increase in revenue to $2.848 million from $2.33
million a year ago, according to the mean estimate from 3
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Nephros Inc is for
a loss
of 11 cents per share. For the same quarter last year, the
company reported a loss of 8 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Nephros Inc
is
$13​, about 65.2% above​ its last closing price of $4.52. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2021  -0.10       -0.10      -0.12     Missed  -14.3
 Jun. 30 2021  -0.11       -0.11      -0.12     Missed  -5.9
 Mar. 31 2021  -0.12       -0.12      -0.11     Beat    7.6​
 Dec. 31 2020  -0.12       -0.11      -0.08     Beat    27.3
 ​​Sep.        -0.14       -0.14      -0.12     Beat    12.2
 30 2020                                                
 Jun. 30 2020  -0.15       -0.15      -0.19     Missed  -26.7​
 Mar. 31 2020  -0.08       -0.08      -0.13     Missed  -62.5
 Dec. 31 2019  -0.11       -0.11      -0.02     Beat    82.4
 This summary was machine generated February 22 at 03:01 GMT. 
All figures in US dollars  unless otherwise stated

Recent news on Nephros

See all news